← SynDRA

PARETHOXYCAINE

SynDRA canonical compound SYN0004503 — structure-anchored drug synonym record

All known targets

• SCN1A
• SCN2A
• SCN3A

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

• GLP1R
• GNAS
• HDAC6
• LMNA

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

• CP1A2
• CP2D6
• INS

Drug classes

• local anesthetic

Cross-references

• PubChem CID: 7183
• ChEMBL: CHEMBL421669
• DrugBank: DB19380
• ChEBI: CHEBI:135095
• RxNorm: 236249

Synonyms

• parethoxycaine hydrochloride
• parethoxycaine HCl
• Paretoxicaina
• Parethoxicainum
• Parethoxycainum
• Parethoxycaine [INN]
• Parethoxycainum [INN-Latin]
• Paretoxicaina [INN-Spanish]
• 4-Ethoxybenzoic acid 2-(diethylamino)ethyl ester
• 2-(diethylamino)ethyl 4-ethoxybenzoate
• BRN 2586492
• beta-(Diethylamino)ethyl-4-ethoxybenzoate
• PARETHOXYCAINE [MI]
• Benzoic acid, p-ethoxy-, 2-(diethylamino)ethyl ester
• PARETHOXYCAINE [WHO-DD]
• DTXCID8026060
• 4-10-00-00396 (Beilstein Handbook Reference)
• Benzoic acid, 4-ethoxy-, 2-(diethylamino)ethyl ester
• Parethoxycainum (INN-Latin)
• Paretoxicaina (INN-Spanish)
• RefChem:858671
• 2-diethylaminoethyl 4-ethoxybenzoate
• NCGC00159450-02
• CAS-94-23-5
• UNII-68E52E5J67
• SCHEMBL25944
• CHEBI:135095
• OWWVHQUOYSPNNE-UHFFFAOYSA-N
• Tox21 111677
• Tox21_111677
• BDBM50225495
• STK095500
• AKOS003658271
• Tox21_111677_1
• NCGC00159450-03
• NCGC00159450-04
• NCGC00159450-05
• AB00452865-09